Human immunodeficiency virus (HIV) Nef is an RNA binding protein in cell-free systems

Journal of Molecular Biology

Volumn 262, Issue 5, 1996, Pages 640-651

  Echarri, Asier ^a   González, Maria Eugenia ^a   Carrasco, Luis ^a  

^a CSIC   (Spain)

Author keywords

HIV; Nef; RNA binding protein

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 10A; GENE PRODUCT; GLYCINE; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; RNA BINDING PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FREE SYSTEM; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CROSS LINKING; DELETION MUTANT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN PURIFICATION; RNA BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PICORNAVIRIDAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030580056     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0542     Document Type: Article

References (81)

1. Ahmad, N. & Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional represser of HIV-1 LTR. Science, 241, 1481-1485.
2. Aiken, C. & Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056.
3. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. & Trono, D. (1994). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell, 76, 853-864.
4. Aldabe, R. & Carrasco, L. (1995). Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem. Biophys. Res. Commun. 206, 64-76.
5. Azad, A. A., Failla, P., Lucantoni, A., Bentley, J., Mardon, C., Wolfe, A., Fuller, K., Hewish, D., Sengupta, S., Sankovich, S., Grgacic, E., McPhee, D. & Macreadie, I. (1994). Large-scale production and characterization of recombinant human immunodeficiency virus type 1 Nef. J. Gen. Virol. 75, 651-655.
6. Bachelerie, F., Alcamí, J., Hazan, U., Israël, N., Goud, B., Arenzana-Seisdedos, F. & Virelizier, J.-L. (1990). Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J. Virol. 64, 3059-3062.
7. Backer, J. M., Mendola, C. E., Fairhurst, J. L. & Kovesdi, I. (1991). The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Res. Hum. Retroviruses, 7, 1015-1020.
8. Bandres, J. C. & Ratner, L. (1994). Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappaB and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68, 3243-3249.
9. Barco, A. & Carrasco, L. (1995). A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J. 14, 3349-3364.
10. Benichou, S., Bomsel, M., Bodéus, M., Durand, H., Douté, M., Letourneur, F., Camonis, J. & Benarous, R. (1994). Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269, 30073-30076.
11. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C. & Cullen, B. R. (1993). Downregulation of cell surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177, 1561-1566.
12. Biamonti, G. & Riva, S. (1994). New insights into the auxiliary domains of eukaryotic RNA binding proteins. FEBS Letters, 340, 1-8.
13. Bienz, K., Egger, D. & Pasamontes, L. (1987). Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology, 160, 220-226.
14. Bienz, K., Egger, D., Pfister, T. & Troxler, M. (1992). Structural and functional characterization of the poliovirus replication complex. J. Virol. 66, 2740-2747.
15. Binninger, D., Ennen, J., Bonn, D., Norley, S. G. & Kurth, R. (1991). Mutational analysis of the simian immunodeficiency virus SIV mac nef gene. J. Virol. 65, 5237-5243.
16. Burd, C. G. & Dreyfuss, G. (1994). Conserved structures and diversity of functions of RNA-binding proteins. Science, 265, 615-621.
17. Chen, X., Sadlock, J. & Schon, E. A. (1993). RNA-binding patterns in total human tissue proteins: analysis by northwestern blotting. Biochem. Biophys. Res. Commun. 191, 18-25.
18. Chenciner, N., Michel, F., Dadaglio, G., Langlada-Demoyen, P., Hoffenbach, A., Leroux, A., Garcia-Pons, F., Rautmann, G., Guy, B., Guillon, J. M., Mayaud, C., Girard, M., Autran, B., Kieny, M. P. & Plata, F. (1989). Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Eur. J. Immunol. 19, 1537-1544.
19. Cheng-Mayer, C., Iannello, P., Shaw, K., Luciw, P. A. & Levy, J. A. (1989). Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science, 246, 1629-1632.
20. Cho, M. W., Teterina, N., Egger, D., Bienz, K. & Ehrenfeld, E. (1994). Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology, 202, 129-145.
21. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman, D. D. & Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
22. Chowers, M. Y., Pandor, M. W., Spina, C. A., Richman, D. D. & Guatelli, J. C. (1995). The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology, 212, 451-457.
23. Citovsky, V., Wong, M. L., Shaw, A. L., Prasad, B. V. & Zambryski, P. (1992). Visualization and characterization of tobacco mosaic virus movement protein binding to single-stranded nucleic acids. Plant Cell, 4, 397-411.
24. Cullen, B. R. (1994). The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology, 205, 1-6.
25. Daniel, M. D., Kirchhoff, F., Czajak, C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science, 258, 1938-1941.
26. De Ronde, A., Klaver, B., Keulen, W., Smit, L. & Goudsmit, J. (1992). Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology, 188, 391-395.
27. Doedens, J. R. & Kirkegaard, K. (1995). Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14, 894-907.
28. Fisher, A. G., Ratner, L., Mitsuya, H., Marselle, L. M., Harper, M. F., Broder, S., Gallo, R. C. & Wong Staal, F. (1986). Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. Science, 233, 655-659.
29. Franchini, G., Robert-Guroff, M., Ghrayeb, J., Chang, N. T. & Wong-Staal, F. (1986). Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells. Virology, 155, 593-599.
30. Garcia, J. V. & Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature, 350, 508-511.
31. Garcia, J. V., Alfano, J. & Miller, A. D. (1993). The negative effect of human immunodefiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J. Virol. 67, 1511-1516.
32. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D. & Greene, W. C. (1995). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112-4121.
33. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. P. (1987). HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature, 330, 266-269.
34. Hahn, B. H., Shaw, G. M., Arya, S. K., Popovic, M., Gallo, R. C. & Wong-Staal, F. (1984). Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature, 312, 166-169.
35. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R. & Greene, W. C. (1989). Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc. Natl Acad. Sci. USA, 86, 9549-9553.
36. Harris, M., Hislop, S., Patsilinacos, P. & Neil, J. C. (1992). In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. AIDS Res. Hum. Retroviruses, 8, 537-543.
37. Huang, Y., Zhang, L. & Ho, D. D. (1995). Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69, 93-100.
38. Jamieson, B. D., Aldrovandi, G. M., Planelles, V., Jowett, J. B. M., Gao, L., Bloch, L. M., Chen, I. S. Y. & Zack, J. A. (1994). Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68, 3478-3485.
39. Kaminchik, J., Bashan, N., Itach, A., Sarver, N., Gorecki, M. & Panet, A. (1991). Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J. Virol. 65, 583-588.
40. Kaminchik, J., Margalit, R., Yaish, S., Drummer, H., Amit, B., Sarver, N., Gorecki, M. & Panet, A. (1994). Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res. Hum. Retroviruses, 10, 1003-1010.
41. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell, 65, 651-662.
42. Kiledjian, M. & Dreyfuss, G. (1992). Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 11, 2655-2664.
43. Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. & Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 86, 9544-9548.
44. Kong, L., Lee, S. W., Kappis, B. H., Parkin, J. S., Decker, D., Haxie, J. A., Hahn, B. H. & Shaw, G. M. (1988). West african HIV-2-related human retrovirus with attenuated cytopathicity. Science, 240, 1525-1539.
45. Kornfeld, H., Riedel, N., Viglianti, G. A., Hirsch, V. & Mullins, J. J. (1987). Cloning of HTLV-4 and its relation to simian and human immunodefiency viruses. Nature, 326, 610-613.
46. Lain, S., Riechmann, J. L. & García, J. A. (1991). RNA helicase: a novel activity associated with a protein encoded by a positive strand RNA virus. Nucl. Acids Res. 18, 7003-7006.
47. Lazinski, D., Grzadzielska, E. & Das, A. (1989). Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell, 59, 207-218.
48. Levy, J. A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
49. Li, J. P. & Baltimore, D. (1990). An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J. Virol. 64, 1102-1107.
50. Lu, Y., Stenzel, M., Sodroski, J. G. & Haseltine, W. A. (1989). Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J. Virol. 63, 4115-4119.
51. Luban, J. & Goff, S. P. (1991). Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 65, 3203-3212.
52. Luciw, P. A., Cheng, Mayer, C. & Levy, J. A. (1987). Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc. Natl Acad. Sci. USA, 84, 1434-1438.
53. Matsuura, Y., Maekawa, M., Hattori, S., Ikegami, N., Hayashi, A., Yamazaki, S., Morita, C. & Takebe, Y. (1991). Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus. Virology, 184, 580-586.
54. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C. & Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
55. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B. & Greene, W. C. (1995). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69, 579-584.
56. +T-cell line. Proc. Natl Acad. Sci. USA, 90, 11895-11899.
57. Nebreda, A. R., Bryan, T., Segade, F., Wingfield, P., Venkatesan, S. & Santos, E. (1991). Biochemical and biological comparison of HIV-1 and ras gene products. Virology, 183, 151-159.
58. Niederman, T. M. J., Thielan, B. & Ratner, L. (1989). Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc. Natl Acad. Sci. USA, 86, 1128-1132.
59. Ovod, V., Lagerstedt, A., Ranki, A., Gombert, F. O., Spohn, R., Tähtinen, M. & Jung, G. (1992). Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS, 6, 25-34.
60. Qiu, Y. & Krug, R. M. (1994). The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly (A). J. Virol. 68, 2425-2432.
61. Ratner, L. (1993). Molecular biology and pathogenesis of HIV infection. Curr. Opin. Infect. Dis. 6, 181-190.
62. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R. C. & Reitz, M. (1990). Structure and expression of tat-, rev, and nef specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64, 3391-3398.
63. Rodriguez, P. L. & Carrasco, L. (1993). Poliovirus protein 2C has ATPase and GTPase activities. J. Biol. Chem. 268, 8105-8110.
64. Rodriguez, P. & Carrasco, L. (1995a). Poliovirus protein 2C contains two regions involved in RNA binding activity. J. Biol. Chem. 270, 10105-10112.
65. Rodriguez, P. L. & Carrasco, L. (1995b). Improved factor Xa cleavage of fusion proteins containing maltose binding protein. Biotechniques, 18, 238-243.
66. Rothman, J. E. (1994). Mechanisms of intracellular protein transport. Nature, 372, 55-63.
67. Römisch, K., Webb, J., Lingelbach, K., Gausepohl, H. & Dobberstein, B. (1990). The 54-kD protein of signal recognition particle contains a methionine-rich RNA binding domain. J. Cell Biol. 111, 1793-1802.
68. + viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
69. Samuel, K. P., Hodge, D. R., Chen, Y. M. & Papas, T. S. (1991). Nef proteins of the human immunodeficiency viruses (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors. AIDS Res. Hum. Retroviruses, 7, 697-706.
70. Sanfridson, A., Cullen, B. R. & Doyle, C. (1994). The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J. Biol. Chem. 269, 3917-3920.
71. Schwartz, O., Rivière, Y., Heard, J.-M. & Danos, O. (1993). Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of nef. J. Virol. 67, 3274-3280.
72. Schwartz, O., Dautry-Varsat, A., Goud, B., Maréchal, V., Subtil, A., Heard, J.-M. & Danos, O. (1995a). Human immunodeficiency virus type 1 nef induces accumulation of CD4 in early endosomes. J. Virol. 69, 528-533.
73. Schwartz, O., Maréchal, V., Danos, O. & Heard, J.-M. (1995b). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059.
74. Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-Moiseiwitsch, F. & Swanstrom, R. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67, 4639-4650.
75. Simos, G. & Hurt, E. C. (1995). Nucleocytoplasmic transport: factors and mechanisms. FEBS Letters, 369, 107-112.
76. Subbramanian, R. A. & Cohen, E. A. (1994). Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68, 6831-6835.
77. Terwilliger, E., Sodroski, G., Rosen, C. A. & Haseltine, W. A. (1986). Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. J. Virol. 60, 754-760.
78. Trono, D. (1995). HIV accessory proteins: leading roles for the supporting cast. Cell, 82, 189-192.
79. Wolber, V., Rensland, H., Brandmeier, B., Sagemann, M., Hoffmann, R., Kalbitzer, H. R. & Wittinghofer, A. (1992). Expression, purification and biochemical characterisation of the human immunodeficiency virus 1 nef gene product. Eur. J. Biochem. 205, 1115-1121.
80. Wong-Staal, F. (1990). Virology (Fields, B. N. & Knipe, D. M., eds), 2nd edit., pp. 1529-1543, Raven Press, Ltd., New York.
81. Yu, G. & Felsted, R. L. (1992). Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology, 187, 46-55.